Details for 2019819804

Up to date per 03.04.2026

Actions

Title / Product Name

ACYLSULFONAMIDE ALS ANTAGONISTEN DER BCL-FAMILIE ZUR VERWENDUNG BEIM KLINISCHEN MANAGEMENT VON ERKRANKUNGEN, DIE DURCH SENESZENTE ZELLEN VERURSACHT ODER VERMITTELT WERDEN, SOWIE ZUR BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019819804

EP Publication Number

3807245

E-Number

1624539

Language

PCT Number

US19037067

Publication Date

21.04.2021 A

25.10.2023 B1

Registration Date

25.10.2023

AT Publication Date

15.11.2023

Application Date

13.06.2019

Registration Number

Priorities

13.06.2018

201862684681 P

IPC

C07D 207/337 20060101AFI20210531BHEP

Maximum Duration of Protection

13.06.2039

Owner

Unity Biotechnology, Inc.285 East Grand Avenue South San Francisco, CA 94080US

Representative

No representatives present

Inventor

BEAUSOLEIL, Anne-Mariec/o Unity Biotechnology, Inc. 285 East Grand Avenue South San Francisco, CA 94080US

HUDSON, Ryanc/o Unity Biotechnology, Inc. 285 East Grand Avenue South San Francisco, CA 94080US